AMN Healthcare Services Inc (AMN)vsJohnson & Johnson (JNJ)
AMN
AMN Healthcare Services Inc
$31.69
+3.53%
HEALTHCARE · Cap: $1.17B
JNJ
Johnson & Johnson
$232.77
+1.07%
HEALTHCARE · Cap: $536.54B
Smart Verdict
WallStSmart Research — data-driven comparison
Johnson & Johnson generates 2718% more annual revenue ($96.36B vs $3.42B). JNJ leads profitability with a 21.8% profit margin vs -0.9%. AMN appears more attractively valued with a PEG of 1.71. AMN earns a higher WallStSmart Score of 62/100 (C+).
AMN
Buy62
out of 100
Grade: C+
JNJ
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+60.2%
Fair Value
$49.13
Current Price
$31.69
$17.44 discount
Margin of Safety
-71.4%
Fair Value
$135.80
Current Price
$232.77
$96.97 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 99.9% year-over-year
Earnings expanding 321.3% YoY
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 26 in profit
Keeps 22 of every $100 in revenue as profit
Strong operational efficiency at 27.4%
Generating 1.5B in free cash flow
Areas to Watch
Expensive relative to growth rate
Smaller company, higher risk/reward
Elevated debt levels
ROE of -4.5% — below average capital efficiency
Moderate valuation
Expensive relative to growth rate
Earnings declined 52.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : AMN
The strongest argument for AMN centers on Revenue Growth, EPS Growth, Price/Book. Revenue growth of 99.9% demonstrates continued momentum.
Bull Case : JNJ
The strongest argument for JNJ centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 21.8% and operating margin at 27.4%.
Bear Case : AMN
The primary concerns for AMN are PEG Ratio, Market Cap, Debt/Equity.
Bear Case : JNJ
The primary concerns for JNJ are P/E Ratio, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
AMN profiles as a hypergrowth stock while JNJ is a mature play — different risk/reward profiles.
AMN carries more volatility with a beta of 0.30 — expect wider price swings.
AMN is growing revenue faster at 99.9% — sustainability is the question.
JNJ generates stronger free cash flow (1.5B), providing more financial flexibility.
Bottom Line
AMN scores higher overall (62/100 vs 59/100) and 99.9% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AMN Healthcare Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
AMN Healthcare Services, Inc. provides healthcare personnel solutions and staffing services to hospitals and healthcare facilities in the United States. The company is headquartered in Dallas, Taxas.
Visit Website →Johnson & Johnson
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?